Synthekine Inc., an engineered cytokine therapeutics company, today announced positive initial results from a Phase 1a/1b clinical trial of STK-012 in first-line, PD-L1 negative nonsquamous (NSQ) ...

Explore Curaleaf Holdings, Inc.'s earnings, market outlook, and upside tied to U.S. cannabis legalization. Click to see if ...

Psychedelics have been studied for treating AUD, but supporting controlled trials are slim. There's much more substantial ...

Many believe that stress always weakens the immune system, making one more prone to illness. However, studies show that ...

What are stereotypes about Nigerians? Discover the truth behind harmful stereotypes, Nigeria's economic impact & how ...

The Foschini Group Limited ( OTCPK:FHNGY) Q2 2026 Earnings Call November 7, 2025 3:00 AM EST ...

Last summer, the 41-year-old suggested 2025 would be his final season. The numbers through eight games suggest maybe he should reconsider.

The wide range of advanced statistics available in today's game has changed the way talent is evaluated and teams are ...

45Q Carbon Capture Credits -- Delayed cash inflow from tax credits is now expected in 2026 due to government shutdown-related ...

Market conditions -- Management described the day labor and temp staffing businesses as generally stable, with some ...

Spatially and temporally overlapping target and distractor are both rhythmically sampled at ~1 Hz, and the phase relationship between target sampling and distractor sampling predicts behavior.

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected revenue range to $1.6 – $2.0 billion Improves 2025 expected GAAP operating ...